Biopharma investor relations
WebInvestor Relations. Latest News. GT Biopharma Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Corporate Update. Mar 30, 2024. Read Press … WebPOINT Biopharma Announces Closing of Agreements with Lantheus Holdings. POINT Biopharma Global Inc. (“POINT”) (NASDAQ: PNT), a company accelerating the discovery, development, and global access to life-changing radiopharmaceuticals, today announced that the closing conditions, including Hart-Scott-Rodino antitrust clearance, have been …
Biopharma investor relations
Did you know?
WebJan 5, 2024 · Investor Relations. Investor/Media Home; Press Releases; Events & Presentations; Analyst Coverage; Stock Information; SEC Filings; Corporate Governance; Investors/Media FAQs - Landos - Investor Tools. Print Page; RSS Feeds; Email Alerts; Landos Biopharma, Inc. PO Box 11239 Blacksburg, VA 24062. … WebApr 10, 2024 · Corporate Overview. RedHill Biopharma (NASDAQ: RDHL) is driven to develop extraordinary medicines for people to live extraordinary lives. RedHill applies …
WebApr 10, 2024 · DUBLIN, April 10, 2024 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will present at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17 at 3:45 pm ET (12:45 pm ... WebSince commencing operations in 2013, we have been working to develop novel, life-changing pharmaceutical products. What distinguishes us is our targeted approach to …
Web1 day ago · SEATTLE, Wash., April 12, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today announced that the management team will participate in two upcoming investor … WebSenior Investor Relations professional and former sell-side biopharmaceuticals analyst. ... Buck was an early researcher of the …
WebSep 13, 2024 · First Wave BioPharma, Inc. (formerly AzurRx BioPharma) is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. First Wave is currently advancing a therapeutic development pipeline populated with multiple clinical stage programs built around its two ...
WebSep 30, 2024 · INVESTOR RELATIONS KEY FIGURES. Kedrion is a leading biopharmaceutical company that specializes in the development, production and distribution of plasma-derived therapeutic products for use in treating serious diseases, disorders and conditions such as immune system deficiencies and coagulation disorders. ipad lightning to usb-cWebAt RedHill Biopharma, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. openoffice auf windows 10 installierenWebThe Board of Directors of 9 Meters Biopharma, Inc. sets high standards for the company’s employees, officers, and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company’s ... openoffice base listenfeldWeb2 days ago · DUBLIN, April 11, 2024 /PRNewswire/ -- Theravance Biopharma, Inc. (" Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced the appointment of Jim Kelly, Managing Director at Weiss Asset Management, the Company's second largest shareholder, to its Board of Directors.With the appointment of Mr. Kelly, … ipad lightsWebDec 31, 2024 · Investor Relations Latest Presentations April 2024 Corporate Presentation View Presentation 102.2 MB. Events There are no events scheduled at this time. View All Events. News Releases 30 Mar 2024 Xeris Biopharma ... a wholly owned subsidiary of Xeris Biopharma Holdings, Inc. All other trademarks are the property of their respective … openoffice base sql commandsWebApr 12, 2024 · Displaying 1 - 10 of 869 results. Data provided by Kaleidoscope. For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc. open office benchingWebMar 14, 2024 · Investor Relations Company Profile. YS Biopharma is a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. ... therapeutic biologics targeting Rabies, Hepatitis B, Shingles, … openoffice auf windows 11 installieren